Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-10-31T23:29:01.844Z Has data issue: false hasContentIssue false

Cardiometabolic risk in patients with schizophrenia

Published online by Cambridge University Press:  16 April 2020

D. Kalnicka
Affiliation:
Charles University, Hradec Kralove, Czech Republic
J. Masopust
Affiliation:
Charles University, Hradec Kralove, Czech Republic
R. Maly
Affiliation:
Charles University, Hradec Kralove, Czech Republic
K. Konupcikova
Affiliation:
Charles University, Hradec Kralove, Czech Republic

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Patients with schizophrenia have at least 20 years shorter life spam compared with general population that is primarily caused by their cardiovascular morbidity.

Aims

The aim of this cross-sectional study was to assess the prevalence of cardiometabolic risk factors in a sample of Czech patients with schizophrenia and related diseases and to predict a risk of premature cardiovascular mortality in this population.

Methods

We reviewed data from 129 outpatients treated in specialized outpatient clinic for psychoses. The main collected variables included basic physical parameters (height, weight, waist circumference, blood pressure), smoking habits, laboratory data (glucose level, serum lipids levels) and ECG. Finally, we compared the studied group with a matched sample from general population in Czech Republic regarding the cardiovascular risk factors.

Results

Our results show that the most prevalent risk factors are overweight (70% of patients have BMI over 25), dyslipidaemia (70% of patients) and smoking (43% of patients). According to SCORE diagram, there is a high risk of fatal cardiovascular event in ten years in 10% of the study group. The percentage gets even higher (up to 24%) when the latest European guidelines for cardiovascular disease prevention were used to calculate the risk.

Conclusions

Our outcomes indicate even higher cardiometabolic morbidity in patients with psychoses than referred in literature.

Type
P03-244
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.